Study
Insulin Glargine and Lantus(R) Trial 1 Insulin Glargine and Lantus(R) Trial 1 - Daytona Beach , FL - #CCRI SD-01
Summary

To compare the effectiveness, safety and tolerability of a newly developed formulation of Insulin Glargine with Lantus(R)

Qualifications - Inclusions & Exclusions

Inclusion:
Patients with Type 2 Diabetes
Age 18 or greater
Have been taking Insulin Glargine greater than 42 units

Exclusion:
Hemoglobin A1c is between 7 and 10,
Diabetes type other than Type 2
Use of an insuline pump in the last 6 months before screening visit
Any contraindication to use of insuline glargine
Diabetic Retinopathywith laser or surgical treatment in the 3 months before screening
Congestive Heart Failure
History of drug or alcohol abuse within the last 3 months prior to screening

Compensation for Time and Travel

Participants who qualify will receive reimbursement for their time and participation for an amount up to $640

Location
Daytona Beach, Volusia County
Daytona Beach, FL 32117
In/Outpatient
Outpatient
Submit the form below to learn more

* Denotes required field.

First Name * Required
Last Name
Comments
First Name *
Last Name *
Email *
Daytime Phone
Evening Phone
Source
If Other
Comments
   Privacy Policy